Drug Allergy: Clinical Trials

13 trials for Drug Allergy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 recruiting, 4 unknown, 1 not yet recruiting. 4 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 1, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 11Completed 1
Phase 21Recruiting 1
Phase 41Unknown 1

Follow Drug Allergy: new trials by email Literature Review of Drug Allergy trials Research Report on Drug Allergy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Provocation After Nurse-Directed Assessment (PANDA) Study
Nurse-led penicillin allergy delabelling service, Allergist-led penicillin allergy delabelling service - Drug Allergy, Penicillin Allergy
RecruitingThe University of Hong Kong4402025-09-012026-04-29
In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping
BL-Predicter - Drug Allergy
Not applicableNot yet recruitingFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud3322025-07-012025-06-08
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy
Phase 2RecruitingMassachusetts General Hospital3002025-05-052026-09-04
Teicoplanin Allergy Testing Using Autologous Serum (TATAS)
Teicoplanin Allergy Testing using autologous serum - Drug Allergy
Not applicableRecruitingUniversity Hospital Southampton NHS Foundation Trust202025-01-082025-01-31
A Training Program of Drug Allergy for Healthcare Professionals
Drug allergy training program - Drug Allergy
Not applicableUnknownThe University of Hong Kong1002024-12-092024-05-06
Inpatient Penicillin Delabeling for Low-Risk Patients
Direct Oral Challenge - Penicillin, Drug Allergy
Phase 4UnknownUniversity of Tennessee252023-09-012024-05-16
High Dimensional Analysis of Immune Cells in Pediatric Patients
Drug Allergy, Neuromuscular Blockade
RecruitingSeoul National University Hospital2942023-04-272024-11-29
Retrospective Study of Immediate Hypersensitivity (IHS) Reactions to Platinum Salts in the University Hospital of Nancy
no intervention - Drug Allergy
UnknownCentral Hospital, Nancy, France622021-06-012021-06-10
Perioperative Hypersensitivity in Children
diagnostics - Drug Allergy
Not applicableCompletedIstanbul University - Cerrahpasa292020-06-302023-01-31
Multiple Drug Hypersensitivity Syndrome
Drug Allergy
CompletedUniversity Hospital, Montpellier502018-12-202019-11-19
Improved Basophil Activation Test (BAT) in the Diagnostics of Drug Allergy
Drug Allergy, Antibiotic Allergy
UnknownThe Republican Research and Practical Center for Epidemiology and Microbiology452017-01-032018-12-17
Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization
Omalizumab - Drug Allergy
Phase 1CompletedDana-Farber Cancer Institute52014-07-012018-02-22
Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study
Adverse Drug Reaction, Drug Allergy
CompletedSuodi ZHAI304002014-01-012016-02-19

Narrower conditions

Drug Hypersensitivity (13)  ·  Anaphylaxis (2)  ·  Hypersensitivity (2)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Hypersensitivity, Immediate (1)

Broader conditions

Chemically-Induced Disorders (13)  ·  Drug-Related Side Effects and Adverse Reactions (12)  ·  Immune System Diseases (4)  ·  Hypersensitivity (2)  ·  Hypersensitivity, Immediate (2)

Interventions

Ampicillin (1)  ·  Cefaclor (1)  ·  Cefadroxil (1)  ·  Cefazolin (1)  ·  Cefdinir (1)  ·  Cefepime (1)  ·  Cefixime (1)  ·  Cefotaxime (1)  ·  Cefpodoxime (1)  ·  Ceftazidime (1)  ·  Ceftriaxone (1)  ·  Cefuroxime (1)  ·  Cephalexin (1)  ·  Histamine (1)  ·  Monobactams (1)

Sponsors

The University of Hong Kong (2)  ·  Central Hospital, Nancy, France (1)  ·  Dana-Farber Cancer Institute (1)  ·  Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (1)  ·  Istanbul University - Cerrahpasa (1)  ·  Massachusetts General Hospital (1)  ·  Seoul National University Hospital (1)  ·  Suodi ZHAI (1)  ·  The Republican Research and Practical Center for Epidemiology and Microbiology (1)  ·  University Hospital Southampton NHS Foundation Trust (1)  ·  University Hospital, Montpellier (1)  ·  University of Tennessee (1)

Countries

United States (3)  ·  France (2)  ·  Hong Kong (2)  ·  Belarus (1)  ·  China (1)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Andrei Hancharou, Dr (1)  ·  Ayca Kiykim (1)  ·  David A Khan, MD (1)  ·  David Hong, MD (1)  ·  Iryna U Ramanava (1)  ·  Kimberly G Blumenthal, MD, MSc (1)  ·  Linda Nel, MB BCh FRCA (1)

Results publications

PMID 41558734

NIH funding

U01AI184071 (1)